In addition to increasing bone mass and reducing blood glucose levels, this study revealed that activating the HIF-1α pathway by specifically knocking out Vhl in osteoblasts partially alleviated the symptoms of STZ-induced T1DM. The gene discussed is HIF1A; the disease is type 1 diabetes mellitus.